Cargando…

High expression of syndecan-4 is related to clinicopathological features and poor prognosis of pancreatic adenocarcinoma

OBJECTIVE: Pancreatic adenocarcinoma (PAAD) is a leading cause of cancer-related mortality in adults. Syndecan-4 (SDC4) is involved in cancer pathogenesis. Therefore, this study aimed to explore the expression and clinical significance of SDC4 in PAAD. METHODS: Differentially expressed genes (DEGs)...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhu, Yufei, Zheng, Dijie, Lei, Linhan, Cai, Kun, Xie, Huahua, Zheng, Jian, Yu, Chao
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2022
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9533499/ https://www.ncbi.nlm.nih.gov/pubmed/36199068 http://dx.doi.org/10.1186/s12885-022-10128-y

Ejemplares similares

circACTG1 Promotes Hepatocellular Carcinoma Progression by Regulating miR-940/RIF1 Axis and Activating AKT/mTOR Pathway
por: Wu, Chunchen, et al.
Publicado: (2022)

Syndecans and Pancreatic Ductal Adenocarcinoma
por: Betriu, Nausika, et al.
Publicado: (2021)

RNF7 Facilitated the Tumorigenesis of Pancreatic Cancer by Activating PI3K/Akt Signaling Pathway
por: Hua, Hao, et al.
Publicado: (2023)

Upregulated CD58 is associated with clinicopathological characteristics and poor prognosis of patients with pancreatic ductal adenocarcinoma
por: Zhang, Yalu, et al.
Publicado: (2021)

Prodigiosin inhibits cholangiocarcinoma cell proliferation and induces apoptosis via suppressing SNAREs-dependent autophagy
por: Zheng, Dijie, et al.
Publicado: (2021)

Down-expression of CD36 in pancreatic adenocarcinoma and its correlation with clinicopathological features and prognosis
por: Jia, Shengnan, et al.
Publicado: (2018)

The effects of CYP24A1 on clinicopathological features and the prognosis of pancreatic ductal adenocarcinoma
por: Gao, Wei, et al.
Publicado: (2020)

Clinicopathological Features and Prognosis of Resected Pancreatic Ductal Adenocarcinoma Patients with Claudin-18 Overexpression
por: Park, Sejun, et al.
Publicado: (2023)

Clinicopathological implications of NQO1 overexpression in the prognosis of pancreatic adenocarcinoma
por: Ji, Meiying, et al.
Publicado: (2017)

Serum Syndecan-1: A Novel Biomarker for Pancreatic Ductal Adenocarcinoma
por: Yablecovitch, Doron, et al.
Publicado: (2022)

Tumor engraftment in patient-derived xenografts of pancreatic ductal adenocarcinoma is associated with adverse clinicopathological features and poor survival
por: Pergolini, Ilaria, et al.
Publicado: (2017)

Expression of c-fos Was Associated with Clinicopathologic Characteristics and Prognosis in Pancreatic Cancer
por: Guo, Jun-Chao, et al.
Publicado: (2015)

Relationship between autophagy and perineural invasion, clinicopathological features, and prognosis in pancreatic cancer
por: Yang, Yan-Hui, et al.
Publicado: (2017)

MICAL1 facilitates pancreatic cancer proliferation, migration, and invasion by activating WNT/β-catenin pathway
por: Cai, Kun, et al.
Publicado: (2022)

Diagnosis, clinicopathological characteristics and prognosis of pulmonary mucinous adenocarcinoma
por: Sun, Fei, et al.
Publicado: (2018)

Decreased LKB1 predicts poor prognosis in Pancreatic Ductal Adenocarcinoma
por: Yang, Jian-Yu, et al.
Publicado: (2015)

Expression of DEK in pancreatic cancer and its correlation with clinicopathological features and prognosis
por: Zhao, Ting, et al.
Publicado: (2019)

Clinicopathological features and prognosis of gastric adenosquamous carcinoma
por: Feng, Fan, et al.
Publicado: (2017)

Podocalyxin Is a Marker of Poor Prognosis in Pancreatic Ductal Adenocarcinoma
por: Saukkonen, Kapo, et al.
Publicado: (2015)

Overexpression in metastatic breast cancer supports Syndecan-1 as a marker of invasiveness and poor prognosis
por: Cerbelli, Bruna, et al.
Publicado: (2022)

Overexpression of OAS1 Is Correlated With Poor Prognosis in Pancreatic Cancer
por: Lu, Lingling, et al.
Publicado: (2022)

High Matrix Metalloproteinase 28 Expression is Associated with Poor Prognosis in Pancreatic Adenocarcinoma
por: Liu, Na, et al.
Publicado: (2021)

Analysis of serum exosomal microRNAs and clinicopathologic features of patients with pancreatic adenocarcinoma
por: Que, Risheng, et al.
Publicado: (2013)

LACTB mRNA expression is increased in pancreatic adenocarcinoma and high expression indicates a poor prognosis
por: Xie, Jian, et al.
Publicado: (2021)

High Expression of Cancer-Derived Glycosylated Immunoglobulin G Predicts Poor Prognosis in Pancreatic Ductal Adenocarcinoma
por: Cui, Ming, et al.
Publicado: (2020)

Clinicopathological features and prognosis of gastric cancer in young patients
por: Liu, Shushang, et al.
Publicado: (2016)

Up-regulation of miR-9 expression predicate advanced clinicopathological features and poor prognosis in patients with hepatocellular carcinoma
por: Cai, Lizhi, et al.
Publicado: (2014)

Corrigendum: Decreased LKB1 predicts poor prognosis in Pancreatic Ductal Adenocarcinoma
por: Yang, Jian-Yu, et al.
Publicado: (2015)

Overexpression of β3 Chains of Laminin-332 is Associated With Clinicopathologic Features and Decreased Survival in Patients With Pancreatic Adenocarcinoma
por: Chen, Jun, et al.
Publicado: (2015)

KRAS and DAXX/ATRX Gene Mutations Are Correlated with the Clinicopathological Features, Advanced Diseases, and Poor Prognosis in Chinese Patients with Pancreatic Neuroendocrine Tumors
por: Yuan, Fei, et al.
Publicado: (2014)

Clinicopathological Features of Gallbladder Papillary Adenocarcinoma
por: Wan, Xueshuai, et al.
Publicado: (2014)

Clinicopathological features and prognosis in elderly gastric cancer patients: a retrospective cohort study
por: Xu, Guanghui, et al.
Publicado: (2018)

Clinicopathological features and prognosis of intestinal hepatoid adenocarcinoma: evaluation of a pooled case series
por: Zeng, Xiangyu, et al.
Publicado: (2017)

Correlation of CD47 Expression with Adverse Clinicopathologic Features and an Unfavorable Prognosis in Colorectal Adenocarcinoma
por: Kim, Hyunsung, et al.
Publicado: (2021)

High Expression of Cancer-Derived Glycosylated Immunoglobulin G Predicts Poor Prognosis in Pancreatic Ductal Adenocarcinoma: Erratum
por: Cui, Ming, et al.
Publicado: (2021)

XPO1 Expression Is a Poor-Prognosis Marker in Pancreatic Adenocarcinoma
por: Birnbaum, David Jérémie, et al.
Publicado: (2019)

Differential expression of RBM5 and KRAS in pancreatic ductal adenocarcinoma and their association with clinicopathological features
por: PENG, JIE, et al.
Publicado: (2013)

Clinicopathological features and prognosis of pseudomyxoma peritonei
por: WANG, HUAN, et al.
Publicado: (2014)

The characteristics of serum lipid spectrum in PanNENs and its correlation with clinicopathological features and prognosis
por: Meng, Yu-Fan, et al.
Publicado: (2023)

Overexpression of GOLPH3 is associated with poor prognosis and clinical progression in pancreatic ductal adenocarcinoma
por: Zhang, Luan-Jing, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_csdbfv8s27b6sen9je9sqj35di